William Mack & Associates
SNY icon

William Mack & Associates’s Sanofi SNY Stock Holding History

William Mack & Associates’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.15K Buy
+222
New +$9.7K ﹤0.01% 409

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

William Mack & Associates's SNY Position: Q3 2026 in Review

William Mack & Associates opened a new position in Sanofi (SNY) in Q3 2026: 222 shares worth $9.15K. The stake represents ﹤0.01% of the portfolio and ranks #409 among its holdings.

577 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • William Mack & Associates held 222 shares of Sanofi worth $9.15K as of Q3 2026.
  • Sanofi was a new William Mack & Associates position in Q3 2026.
  • Sanofi made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #409 holding.
  • 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.